The platform –called EstiDATA - provides cost estimation and financial modeling for pharmaceutical processes, APIs, and intermediate manufacturing, by combining facility costs, material prices, and supply sources.
“The costs we use are blended averages that we have arrived at on the basis of a number of proposals over the years coupled with what we know about manufacturing,” David Perritt, Rondaxe, VP of Business Development told Outsourcing-Pharma.com.
The system can be customised Perritt continued, adding that “a CMO can use a cheaper rate for one building and a higher rate for a brand new building.”
“If you can determine your cost driver before manufacturing, you can determine how much you can save,” added Perritt.
The software allows users go to through each step and determine what the cost drivers are - which, from a CMO perspective, helps create accurate bids.
For a bigger pharma companies, it helps determine “do I make or do I buy”; for smaller companies, it helps clarify bids to determine from whom to buy.
“Everybody operates from the same assumptions,” added Perritt.
Preparing for tech transfer
As biotech or small pharma companies are looking for investment dollars to further development and manufacturing, or to acquire a partner or merge with a larger company, “you need to be prepared in all aspects of your data in order to have a clean tech transfer,” said Perritt.
CentraDATA, the company’s second application in the new software suite, helps company’s prepare data in a contextual format - materials and batch record information can be entered for root-and-branch searches of related lots.
Additionally, all data derived from the application can be shared with individual groups, organizations, or partners, such as CMOs.
“It allows you to take a look at your data across the board, putting it into a centralized and organized system, so it doesn’t get lost,” Perritt explained.